U.S. flag

An official website of the United States government

GTR Home > Tests > CYP2D6 genotyping


Test name


CYP2D6 genotyping

Purpose of the test


This is a clinical test intended for Help: Drug Response



Click Indication tab for more information.

How to order


Order URL Help: http://www.alphagenomix.com


Molecular Genetics
TTargeted variant analysis
  • ABI QuantStudio 12K plus AccuFil system
  • TaqMan OpenArray, TaqMan Copy Number Assays

Summary of what is tested

Click Methodology tab for more information.

Clinical utility


Not provided

Clinical validity


Not provided

Practice guidelines

  • DailyMed Drug Label, 2020
    DailyMed Drug Label, DESIPRAMINE HYDROCHLORIDE tablet, 2020
  • DailyMed Drug Label, 2019
    DailyMed Drug Label, desipramine, 2019
  • CPIC, 2017
    Clinical pharmacogenetics implementation consortium guideline (CPIC) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update
  • CPIC, 2013
    Clinical Pharmacogenetics Implementation Consortium guideline for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants. (See 2016 Update)

Consumer resources

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.